NASDAQ:CSBR
Champions Oncology Stock News
$4.76
+0.0600 (+1.28%)
At Close: May 20, 2024
Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript
07:21pm, Tuesday, 12'th Mar 2024
Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript
Champions Oncology Reports Quarterly Revenue of $12.0 Million
04:30pm, Tuesday, 12'th Mar 2024
HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today ann
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
09:00am, Thursday, 07'th Mar 2024
HACKENSACK, NJ / ACCESSWIRE / March 7, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
04:35pm, Wednesday, 06'th Mar 2024
HACKENSACK, NJ / ACCESSWIRE / March 6, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its f
Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript
05:54pm, Tuesday, 12'th Dec 2023
Champions Oncology, Inc. (NASDAQ:CSBR ) Q2 2024 Earnings Conference Call December 12, 2023 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Operator Greetings. Welcome to the Cha
Champions Oncology Reports Quarterly Revenue of $11.6 Million
04:00pm, Tuesday, 12'th Dec 2023
HACKENSACK, NJ / ACCESSWIRE / December 12, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
04:30pm, Monday, 04'th Dec 2023
HACKENSACK, NJ / ACCESSWIRE / December 4, 2023 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report it
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
08:30am, Thursday, 02'nd Nov 2023
HACKENSACK, NJ / ACCESSWIRE / November 2, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announc
Champions Oncology Announces the Addition of Brady Davis as President
08:30am, Tuesday, 17'th Oct 2023
HACKENSACK, NJ / ACCESSWIRE / October 17, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, has app
Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript
01:34pm, Friday, 15'th Sep 2023
Champions Oncology, Inc. (NASDAQ:CSBR ) Q1 2024 Earnings Conference Call September 13, 2023 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Matt Hew
Champions Oncology Reports Quarterly Revenue of $12.6 Million
04:00pm, Wednesday, 13'th Sep 2023
HACKENSACK, NJ / ACCESSWIRE / September 13, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
04:00pm, Monday, 11'th Sep 2023
HACKENSACK, NJ / ACCESSWIRE / September 11, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmac
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
08:30am, Tuesday, 22'nd Aug 2023
HACKENSACK, NJ / ACCESSWIRE / August 22, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, kicks-of
HACKENSACK, NJ / ACCESSWIRE / August 1, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global preclinical and clinical research services provider that offers end-to-end oncology R&D solution
Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript
06:34pm, Monday, 24'th Jul 2023
Champions Oncology, Inc. (NASDAQ:CSBR ) Q4 2023 Earnings Conference Call July 24, 2023 4:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Officer Co
